Compare Stocks: TNON, QNRX, FEMY, and HSCS

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
FEMY Femasys	$3.01 -1.3%	$4.36	$2.64 ▼ $22.20	$9.09M	-2.08	48,733 shs	30,409 shs
HSCS HeartSciences	$2.28 +9.6%	$2.31	$1.63 ▼ $3.93	$8.89M	1.79	978,500 shs	71,993 shs
QNRX Quoin Pharmaceuticals	$4.37 +0.5%	$4.48	$3.25 ▼ $41.80	$8.78M	1.5	147,553 shs	6,369 shs
TNON Tenon Medical	$0.19 -0.4%	$0.39	$0.18 ▼ $1.74	$2.27M	1.39	3.52 million shs	1.21 million shs

The 10 Best High-Yield Dividend Stocks for 2026

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
FEMY Femasys	+2.69%	+4.45%	-26.86%	-66.34%	-81.13%
HSCS HeartSciences	-2.80%	-7.96%	-25.45%	+14.92%	-36.97%
QNRX Quoin Pharmaceuticals	-2.25%	+3.57%	-5.02%	-32.35%	-35.84%
TNON Tenon Medical	+1.32%	+1.26%	-34.14%	-74.21%	-86.25%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
FEMY Femasys	$3.01 -1.3%	$4.36	$2.64 ▼ $22.20	$9.09M	-2.08	48,733 shs	30,409 shs
HSCS HeartSciences	$2.28 +9.6%	$2.31	$1.63 ▼ $3.93	$8.89M	1.79	978,500 shs	71,993 shs
QNRX Quoin Pharmaceuticals	$4.37 +0.5%	$4.48	$3.25 ▼ $41.80	$8.78M	1.5	147,553 shs	6,369 shs
TNON Tenon Medical	$0.19 -0.4%	$0.39	$0.18 ▼ $1.74	$2.27M	1.39	3.52 million shs	1.21 million shs

The 10 Best High-Yield Dividend Stocks for 2026

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
FEMY Femasys	+2.69%	+4.45%	-26.86%	-66.34%	-81.13%
HSCS HeartSciences	-2.80%	-7.96%	-25.45%	+14.92%	-36.97%
QNRX Quoin Pharmaceuticals	-2.25%	+3.57%	-5.02%	-32.35%	-35.84%
TNON Tenon Medical	+1.32%	+1.26%	-34.14%	-74.21%	-86.25%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
FEMY Femasys	2.50	Moderate Buy	$106.67	3,443.74% Upside
HSCS HeartSciences	2.00	Hold	$8.00	250.88% Upside
QNRX Quoin Pharmaceuticals	2.00	Hold	N/A	N/A
TNON Tenon Medical	2.00	Hold	N/A	N/A

Current Analyst Ratings Breakdown

Latest TNON, QNRX, FEMY, and HSCS Analyst Ratings

Date	Company	Brokerage	Action	Rating
7/31/2026	FEMY Femasys	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
7/20/2026	QNRX Quoin Pharmaceuticals	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
7/17/2026	TNON Tenon Medical	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
7/16/2026	FEMY Femasys	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
6/24/2026	HSCS HeartSciences	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
6/15/2026	QNRX Quoin Pharmaceuticals	ThinkEquity Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy
6/3/2026	FEMY Femasys	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
5/18/2026	FEMY Femasys	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
5/13/2026	TNON Tenon Medical	Alliance Global Partners Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy

(Data available from 8/5/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
FEMY Femasys	$2.29M	3.97	N/A	N/A	$2.01 per share	1.50
HSCS HeartSciences	N/A	N/A	N/A	N/A	$0.07 per share	N/A
QNRX Quoin Pharmaceuticals	N/A	N/A	N/A	N/A	$15.64 per share	N/A
TNON Tenon Medical	$3.94M	0.58	N/A	N/A	$0.18 per share	1.07

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
FEMY Femasys	-$18.63M	-$5.40	N/A	N/A	N/A	-521.97%	-258.08%	-73.72%	8/12/2026 (Estimated)
HSCS HeartSciences	-$9.14M	-$3.94	N/A	N/A	N/A	N/A	-358.60%	-144.82%	9/10/2026 (Estimated)
QNRX Quoin Pharmaceuticals	-$15.81M	-$29.56	N/A	N/A	N/A	N/A	-489.85%	-221.29%	8/6/2026 (Estimated)
TNON Tenon Medical	-$12.56M	-$1.29	N/A	N/A	N/A	-270.09%	-907.60%	-110.17%	8/13/2026 (Estimated)

Latest TNON, QNRX, FEMY, and HSCS Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/13/2026	Q2 2026	TNON Tenon Medical	-$0.24	N/A	N/A	N/A	$1.54 million	N/A
8/12/2026	Q2 2026	FEMY Femasys	-$1.2667	N/A	N/A	N/A	$0.73 million	N/A
8/6/2026	Q2 2026	QNRX Quoin Pharmaceuticals	-$1.61	N/A	N/A	N/A	N/A	N/A
7/23/2026	Q4 2026	HSCS HeartSciences	-$0.66	-$0.88	-$0.22	-$0.87	$0.05 million	N/A
5/12/2026	Q1 2026	TNON Tenon Medical	-$0.3050	-$0.31	-$0.0050	-$0.31	$1.30 million	$1.38 million
5/8/2026	Q1 2026	FEMY Femasys	-$1.3334	$0.0980	+$1.4314	N/A	$0.77 million	$0.42 million
5/7/2026	Q1 2026	QNRX Quoin Pharmaceuticals	-$2.17	-$1.77	+$0.40	-$1.77	N/A	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
FEMY Femasys	N/A	N/A	N/A	N/A	N/A
HSCS HeartSciences	N/A	N/A	N/A	N/A	N/A
QNRX Quoin Pharmaceuticals	N/A	N/A	N/A	N/A	N/A
TNON Tenon Medical	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
FEMY Femasys	0.53	3.91	1.98
HSCS HeartSciences	N/A	0.53	0.40
QNRX Quoin Pharmaceuticals	N/A	2.87	2.87
TNON Tenon Medical	N/A	1.03	0.92

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
FEMY Femasys	65.27%
HSCS HeartSciences	17.24%
QNRX Quoin Pharmaceuticals	8.63%
TNON Tenon Medical	22.74%

Insider Ownership

Company	Insider Ownership
FEMY Femasys	7.75%
HSCS HeartSciences	4.90%
QNRX Quoin Pharmaceuticals	11.17%
TNON Tenon Medical	17.71%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
FEMY Femasys	30	3.02 million	2.79 million	Not Optionable
HSCS HeartSciences	10	3.90 million	3.71 million	Not Optionable
QNRX Quoin Pharmaceuticals	4	2.01 million	1.78 million	Not Optionable
TNON Tenon Medical	8	11.85 million	9.75 million	Not Optionable

TNON, QNRX, FEMY, and HSCS Headlines

Recent News About These Companies

Tenon Medical, Inc. Sets Date for Second Quarter 2026 Earnings

July 30, 2026 | accessnewswire.comA

Tenon Medical Shareholders Approve Reverse Split and Financings

July 24, 2026 | tipranks.com

Tenon Medical regains Nasdaq compliance

July 20, 2026 | seekingalpha.com

Tenon Medical Regains Nasdaq Listing Compliance After Offering

July 20, 2026 | tipranks.com

Tenon Medical, Inc. Announces Regained Compliance with Nasdaq Stockholders' Equity Requirement

July 20, 2026 | accessnewswire.comA

Tenon Medical Raises Capital, Regains Nasdaq Equity Compliance

July 10, 2026 | tipranks.com

Tenon Medical Completes $4.2 Million Public Offering

July 2, 2026 | tipranks.com

Tenon Medical(R) Announces FDA 510(k) Clearance for Catamaran(R) SI Joint Fusion System

July 2, 2026 | accessnewswire.comA

WallachBeth Capital Announces Closing of Tenon Medical, Inc. $4.2 Million Public Offering

July 1, 2026 | prnewswire.com

Tenon Medical, Inc. Announces Closing of $4.2 Million Public Offering

July 1, 2026 | accessnewswire.comA

Tenon Medical prices $4.2M public offering

June 30, 2026 | msn.com

WallachBeth Capital Announces Pricing of Tenon Medical, Inc. $4.2 Million Public Offering

June 30, 2026 | prnewswire.com

Tenon Medical, Inc. Announces Pricing of $4.2 Million Public Offering

June 30, 2026 | accessnewswire.comA

Tenon Medical (TNON) stock jumps nearly 83% after hours: Here's what is going on

June 19, 2026 | msn.com

Tenon Medical Extends Executive Chairman Consulting Agreement

June 12, 2026 | tipranks.com

Tenon Medical Updates Bylaws to Ease Shareholder Quorum

June 11, 2026 | tipranks.com

Tenon Medical Faces Nasdaq Deficiency, Compliance Plan Due

May 22, 2026 | tipranks.com

Tenon Medical CEO Foster buys $25k in TNON stock and warrants

May 16, 2026 | investing.com

Tenon Medical, Inc. (NASDAQ:TNON) Q1 2026 Earnings Call Transcript

May 13, 2026 | insidermonkey.com

Tenon Medical Earnings Call Highlights Rapid Growth Pivot

May 13, 2026 | tipranks.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

TNON, QNRX, FEMY, and HSCS Company Descriptions

Femasys NASDAQ:FEMY

$3.01 -0.04 (-1.31%)

Closing price 04:00 PM Eastern

Extended Trading

$3.08 +0.08 (+2.49%)

As of 04:13 PM Eastern

Femasys Inc., a biomedical company, develops therapeutic and diagnostic solutions to address unmet women healthcare needs worldwide. The company provides FemVue saline-air device, a contrast-generating product in the United States, Canada, Japan, and Hong Kong; FemCath, a cornual balloon catheter, a single intrauterine directional delivery product that allows for selective evaluation of an individual fallopian tube; and FemCerv, a biopsy device for endocervical curettage, which can be used to sample cervical cells and tissue circumferentially with sample containment within the device to minimize contamination. It also develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing. The company offers its products to reproductive endocrinologists for infertility products, obstetrics-gynecological physicians, related healthcare professionals, and women's healthcare provider organizations. Femasys Inc. was incorporated in 2004 and is headquartered in Suwanee, Georgia.

HeartSciences NASDAQ:HSCS

$2.28 +0.20 (+9.62%)

Closing price 04:00 PM Eastern

Extended Trading

$2.33 +0.05 (+1.97%)

As of 04:10 PM Eastern

Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.

Quoin Pharmaceuticals NASDAQ:QNRX

$4.37 +0.02 (+0.46%)

Closing price 04:00 PM Eastern

Extended Trading

$4.26 -0.11 (-2.59%)

As of 04:19 PM Eastern

Quoin Pharmaceuticals, Ltd., a clinical stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases. Its lead product is QRX003, a topical lotion to treat Netherton Syndrome (NS). The company is also developing QRX004 for the treatment of recessive dystrophic epidermolysis bullosa; QRX007 to treat NS; and QRX008 for the treatment of scleroderma. It has a research agreement with Queensland University of Technology; a license agreement with Skinvisible Inc.; consulting agreements with Axella Research LLC; and a Master Service Agreement with Therapeutics Inc. The company was founded in 2018 and is based in Ashburn, Virginia.

Tenon Medical NASDAQ:TNON

$0.19 0.00 (-0.36%)

Closing price 04:00 PM Eastern

Extended Trading

$0.19 +0.00 (+0.10%)

As of 04:14 PM Eastern

Tenon Medical, Inc., a medical device company, engages in the development of surgical implant systems to treat severe lower back pain in the United States and Puerto Rico. The company offers CATAMARAN SI-Joint Fusion System to fuse sacroiliac joints (SI-Joints) to treat SI-Joint dysfunction that often causes severe lower back pain; and features fixation device that passes through the axial and sagittal planes of the ilium and sacrum, as well as transfixes the SI joints. Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Gatos, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest TNON, QNRX, FEMY, and HSCS Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest TNON, QNRX, FEMY, and HSCS Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

TNON, QNRX, FEMY, and HSCS Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

TNON, QNRX, FEMY, and HSCS Company Descriptions

Femasys NASDAQ:FEMY

HeartSciences NASDAQ:HSCS

Quoin Pharmaceuticals NASDAQ:QNRX

Tenon Medical NASDAQ:TNON

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest TNON, QNRX, FEMY, and HSCS Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest TNON, QNRX, FEMY, and HSCS Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

TNON, QNRX, FEMY, and HSCS Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

TNON, QNRX, FEMY, and HSCS Company Descriptions

Femasys NASDAQ:FEMY

HeartSciences NASDAQ:HSCS

Quoin Pharmaceuticals NASDAQ:QNRX

Tenon Medical NASDAQ:TNON

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools